ABIOMED INC. - Daily - Technical analysis published on 10/16/2019 (GMT)
- 248
- 0
- Who voted?
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : INVALID
ABIOMED INC. Chart
Summary of the analysis
Trends
Court terme:
Neutral
De fond:
Bearish
Technical indicators
56%
17%
28%
My opinion
Bearish under 199.74 USD
My targets
159.31 USD (-10.57%)
103.82 USD (-41.72%)
My analysis
Has the basic bearish trend slowed or is it lacking in power? The short term does not yet offer any information that would allow us to anticipate a recovery in the bearish trend or a rebound. Sellers” generally have the upper hand, even if a small correction (not tradeable) on the resistance located at 199.74 USD remains possible. It is advisable to trade ABIOMED INC. with the greatest caution, while favouring short positions (for sale) as long as the price remains well below 199.74 USD. The next bearish objective for sellers is set at 159.31 USD. A bearish break of this support would revive the bearish momentum. The sellers could then target the support located at 103.82 USD. In case of crossing, the next objective would be the support located at 71.00 USD. PS: if there is a bullish break in the resistance located at 199.74 USD we suggest that you produce a new automated technical analysis. In fact, conditions should have changed. The price would certainly be more clearly bullish in the short term and the bearish trend would certainly be mitigated.
Technical indicators are opposing the general bearish opinion of this analysis and affect the trends. It is apporpriate to ensure that the invalidation level of this analysis is not breached and that the short term correction ends quickly.
FORCE
0
10
2
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay.
Additional analysis
Quotes
ABIOMED INC. rating 178.14 USD. The price has increased by +0.15% since the last closing and was between 175.67 USD and 178.89 USD. This implies that the price is at +1.41% from its lowest and at -0.42% from its highest.175.67
178.89
178.14
The Central Gaps scanner detects a bearish opening. A small advantage for sellers in the very short term.
Bearish opening
Type : Bearish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Technical
Technical analysis of this Daily chart of ABIOMED INC. indicates that the overall trend is bearish. 75% of the signals given by moving averages are bearish. Caution: as the signals currently given by short-term moving averages are rather neutral, the bearish trend could slow down. There is no crossing of moving average by the price or crossing of moving averages between themselves.
In fact, 10 technical indicators on 18 studied are currently positioned bullish. Caution: the Central Indicators scanner currently detects an excess:
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : Daily
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
Momentum indicator is back over 0
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found this result:
Near resistance of channel
Type : Bearish
Timeframe : Daily
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 71.00 | 103.82 | 159.31 | 178.14 | 199.74 | 251.85 | 279.71 |
| Change (%) | -60.14% | -41.72% | -10.57% | - | +12.13% | +41.38% | +57.02% |
| Change | -107.14 | -74.32 | -18.83 | - | +21.60 | +73.71 | +101.57 |
| Level | Minor | Major | Major | - | Intermediate | Major | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 171.71 | 173.68 | 175.77 | 177.74 | 179.83 | 181.80 | 183.89 |
| Camarilla | 176.75 | 177.13 | 177.50 | 177.87 | 178.24 | 178.61 | 178.99 |
| Woodie | 171.78 | 173.71 | 175.84 | 177.77 | 179.90 | 181.83 | 183.96 |
| Fibonacci | 173.68 | 175.23 | 176.19 | 177.74 | 179.29 | 180.25 | 181.80 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 140.50 | 147.76 | 158.70 | 165.96 | 176.90 | 184.16 | 195.10 |
| Camarilla | 164.64 | 166.30 | 167.97 | 169.64 | 171.31 | 172.98 | 174.65 |
| Woodie | 142.34 | 148.68 | 160.54 | 166.88 | 178.74 | 185.08 | 196.94 |
| Fibonacci | 147.76 | 154.71 | 159.01 | 165.96 | 172.91 | 177.21 | 184.16 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 146.61 | 160.30 | 169.10 | 182.79 | 191.59 | 205.28 | 214.08 |
| Camarilla | 171.71 | 173.77 | 175.83 | 177.89 | 179.95 | 182.01 | 184.08 |
| Woodie | 144.16 | 159.08 | 166.65 | 181.57 | 189.14 | 204.06 | 211.63 |
| Fibonacci | 160.30 | 168.90 | 174.20 | 182.79 | 191.39 | 196.69 | 205.28 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 49.64 | |
| MACD (12,26,9): | -5.1200 | |
| Directional Movement: | -7.08 | |
| AROON (14): | -71.43 | |
| DEMA (21): | 166.90 | |
| Parabolic SAR (0,02-0,02-0,2): | 157.35 | |
| Elder Ray (13): | 4.84 | |
| Super Trend (3,10): | 177.91 | |
| Zig ZAG (10): | 177.37 | |
| VORTEX (21): | 0.8900 | |
| Stochastique (14,3,5): | 76.86 | |
| TEMA (21): | 169.65 | |
| Williams %R (14): | -12.04 | |
| Chande Momentum Oscillator (20): | -0.19 | |
| Repulse (5,40,3): | 4.1500 | |
| ROCnROLL: | -1 | |
| TRIX (15,9): | -0.5400 | |
| Courbe Coppock: | 13.04 |
| MA7: | 168.96 | |
| MA20: | 174.45 | |
| MA50: | 184.22 | |
| MA100: | 221.02 | |
| MAexp7: | 172.56 | |
| MAexp20: | 174.74 | |
| MAexp50: | 189.90 | |
| MAexp100: | 214.70 | |
| Price / MA7: | +5.43% | |
| Price / MA20: | +2.12% | |
| Price / MA50: | -3.30% | |
| Price / MA100: | -19.40% | |
| Price / MAexp7: | +3.23% | |
| Price / MAexp20: | +1.95% | |
| Price / MAexp50: | -6.19% | |
| Price / MAexp100: | -17.03% |
News
The last news published on ABIOMED INC. at the time of the generation of this analysis was as follows:
- Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification
- MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- Abiomed Announces 1,000th Patient Treated with Impella in Japan
- Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock; Escalation Protocols Initiated
- PROTECT III Presented at TCT 2019 – Clinical Data Demonstrates Protected PCI with Impella is Associated with Improved Outcomes
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis ABIOMED INC. - Daily